Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
Crossref DOI link: https://doi.org/10.1007/s13300-023-01392-7
Published Online: 2023-03-31
Published Print: 2023-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deerochanawong, Chaicharn
Krittayaphong, Rungroj
Romano, Jack Garcia Uranga
Rhee, Nicolai A.
Permsuwan, Unchalee http://orcid.org/0000-0002-6909-2789
Text and Data Mining valid from 2023-03-31
Version of Record valid from 2023-03-31
Article History
First Online: 31 March 2023